Ingabe i-Psoriasis Yandisa I-Lymphoma Risk?

Ucwaningo lwamuva luthole ingozi encane kodwa okwenziwe ngokoqobo ngezibalo ze-lymphoma kanye nezinye ezinye izinhlobo zomdlavuza ezigulini ezine-psoriasis. Kodwa, kungase kube nokuningi kule ndaba kunokuhlangana nehlo.

I-Psoriasis

I-Psoriasis ingenye yezifo zesikhumba ezivame kakhulu, ezihlotshaniswa nezimpawu ezinjengobuthi, ubuhlungu, noma ukuphuma. Izindawo ezibandakanyekile zesikhumba zibonakala njengezibomvu, izindawo eziphakanyisiwe ezibizwa ngokuthi ama-plates, okungase zihlanganiswe ngokukhipha ukuthungatha okukhulu.

Izinhlobo ezahlukene ze-psoriasis zingaba nemibono ehlukene kanye namaphethini ahlukene esikhumba esithintekayo.

I-Psoriasis ibhekwa njengesimo sokuvuvukala kwesistimu , okungase sibe nomthelela-futhi wabelane ngezimo eziyingozi nezinye izifo, kuhlanganise nokuhlukunyezwa okuthile. Futhi abantu abane-psoriasis babonakala behlangana nezinye izifo ezihlobene nezifo ezingaphezu kwalokho ezingalindelwe ngokusekelwe ezinombeni ezivela kubantu jikelele, kufaka phakathi:

Lymphoma

I-Lymphoma ingumdlavuza ochaphazela i-lymphocytes, uhlobo lwe-white cell seli elitholakala egazini futhi elitholakala ematheni nasemasosini . I-Hodgkin's lymphoma, noma i-HL, ne- non-Hodgkin's lymphoma , noma iNHL, yizigaba ezimbili eziyinhloko ze-lymphoma.

Ngenxa yokuthi i-lymphocytes iyingxenye yesimiso somzimba sokuzivikela, abacwaningi baye bazibuza mayelana nokuxhumana phakathi kwezifo ze-immune ne-lymphoma.

Kuze kube manje, baqhubeka bezama ukuqonda ubuhlobo phakathi kwalaba ababili.

I-Psoriasis & Lymphoma: I-Link

I-American Cancer Society (ACS) okwamanje ayihlaziyi i-psoriasis ngokukhethekile njengengozi engozini ye-lymphoma. Kodwa-ke, zifaka izifo ezithathelwanayo ngokuzenzakalelayo ohlwini lwazo zezinto eziyingozi ze-NHL, okubhekisela ku-arthritis ye-rheumatoid kanye ne-systic lupus erythematosus njengezibonelo.

I-arthritis ye-rheumatoid, i-psoriasis, nesifo sofuba (IBD) sonke sibonisiwe ukuthi ihlotshaniswa nengozi eyengeziwe ye-lymphoma kwezinye, kodwa hhayi zonke izifundo.

Isivikelo somzimba esingasebenzi ngokweqile ngezifo ezizimele singenza ukuthi i-lymphocytes ikhule futhi ihlukanise kaningi kunokujwayelekile, okwandisa ingozi ye-lymphoma. Njengoba i-ACS ibonisa, noma kunjalo, abantu abathola i-NHL bangase babe nezinkinga ezimbalwa noma azikho; futhi noma ngabe umuntu onesi-NHL unesisindo esisodwa noma ngaphezulu, kubhekana kanzima ukwazi ukuthi lezi zingqinamba zingase zibe nomthelela kangakanani ku-lymphoma.

Amanani okukhula kwe-lymphoma kuye kwabikwa ezincwadini eziningi zeziguli ezine-psoriasis. Futhi ingozi ye-lymphoma nama-biological agents, ngokujwayelekile, bekuyisihloko sempikiswano enkulu. Ama-biologic agents anendima ekwelapheni izifo ezifana ne-rheumatoid arthritis ne-psoriasis. Ngenkathi ziye zaboniswa ukuthi ziphephile, zisebenza ngokucindezela isimiso somzimba sokuzivikela-ngakho kukhona ukukhathazeka ukuthi lokhu kungabangela ingozi yezinye umdlavuza.

Kungase kube nokwanda kwengozi yamagciwane e-lymphoma kubantu abane psoriasis, kodwa kunezinselele ezimbalwa ekutadisheni lolu hlobo lokuxhumanisa:

  1. Ngisho noma i-lymphoma inokubaluleka kokubaluleka komphakathi, isibalo sinobuqhathaniswa kuqhathaniswa ne-psoriasis, okwenze kwaba nzima ukuthola izinombolo eziphakeme ukuhlaziya.
  2. Ukuba ne-psoriasis kubandakanya izibalo eziningana, njengokubhema, ukukhuluphala, kanye nokwelashwa kwe-ultraviolet nezidakamizwa ezivimbela isimiso somzimba sokuzivikela. Lezi zici zingandisa ingozi ye-lymphoma nezinye izifo zomdlavuza, ngaphandle kwe-psoriasis ngokwayo.

Muva nje, abacwaningi bahlaziya amarekhodi avela kuma-198,366 abagulayo abane-psoriasis nabangu-937.716 ngaphandle kwe-psoriasis besebenzisa i-database e-United Kingdom. Imiphumela yabonisa ukuthi kwakukhona ingozi encane kodwa "engokwemvelo" eyandisa ingculaza yesikhumba esingenayo i-melanoma, i-lymphoma, nomdlavuza wamaphaphu kubantu abano-psoriasis.

Laba baphandi bathola ukuthi ingozi yomdlavuza yayiphakamise kakhulu kuneziguli ezabekwa ngokuthi zine-psoriasis enesimo esincane ngokumelene nezifo ezincane. Kwakungekho ukuhlangana okuphawulekayo phakathi kwe-psoriasis nomdlavuza webele, i-colon, i-prostate, noma i-leukemia, noma kunjalo.

Ngokudlulile kakhulu, odokotela baseCentral for Dermatology Research eWake Forest School of Medicine eWinston-Salem, eNorth Carolina, baqhuba isifundo esilandelayo. Baqaphele ukuthi i-psoriasis ihlotshaniswa nezinye izimo eziningi zempilo ezihlukahlukene noma ama-comorbidities.

Baye bazizwa ukuthi ukulingana kwengozi evela kuma-psoriasis-okuvame ukubikwa odokotela kanye neziguli njengengozi ehlobene-kungase kungabi yisilinganiso esihle kakhulu. Nakuba ingozi ehambisanayo ingaba usizo, abalobi babecabanga ukuthi ukucabanga ngezingozi ngokwemibandela, kunokuba kube nemigomo ephelele, kuzothatha abantu ukuba baveze umphumela we-psoriasis.

Ngakho-ke, iqembu locwaningo lenzelwe ukubala ingozi ephelele eyenziwa nge-psoriasis yezifo ezihlukahlukene. Izimo ezixhunywe kakhulu nge-psoriasis kakhulu (ezinengozi ephakeme kakhulu) zaziyi-cancer ye-nonmelanoma yesikhumba, i-melanoma, ne-lymphoma njengoba kuboniswe lapha:

Isifo Esithintekayo Sengculazi Inombolo Yengozi Ye-Psoriasis-Risk Number of Patients

Umdlavuza wesikhumba 7.5 0.64 1,551

I-Melanoma 6.12 0.05 29,135

I-Lymphoma 3.61 0.17 5,823

* Ukuze afake isifo esisodwa se-lymphoma kuya kwi-psoriasis, udokotela kufanele abone iziguli ezingu-5,823 ezine-psoriasis.

Imithombo:

Saleem M, UCesty C, uFeldman S. Ukubhekisana nengozi ephelele ye-comorbidities kwiziguli ezine-psoriasis. J Am Acad Dermatol . 2016 Dec 13. pii: S0190-9622.

I-Fuxench ZC, i-Shin DB, i-Beatty AO, i-Gelfand JM. Ingozi yomdlavuza ezigulini ezine-psoriasis: isifundo seqembu esisekelwe kubantu eNhlanganweni Yokuthuthukisa Ezempilo [eshicilelwe kuyi-intanethi ngaphambi kokuphrinta ku-December 16, 2015]. I-JAMA i-Oncol.

Boehncke WH, Boehncke S. Ngaphezu kesikhumba-esijulile: ubukhulu obukhulu besifo se-psoriatic. I-Swiss Med Wkly. 2014; 144: w13968.